TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  The Motley Fool

Billionaire Israel "Izzy" Englander Has Loaded Up on This Dividend King. Should You?

The Motley Fool Logo The Motley Fool By Keith Speights
Billionaire Israel

Billionaire investor Izzy Englander significantly increased his stake in AbbVie, a pharmaceutical company with a strong dividend history and promising drug pipeline, suggesting potential investment opportunity.

Insights
ABBV   positive

Strong drug pipeline with Skyrizi and Rinvoq, attractive valuation (forward P/E of 16.8), consistent dividend increases for 53 consecutive years, and successful navigation of Humira's patent expiration